WBRBF yields 2.92% · PFE yields 6.13%● Live data
📍 WBRBF pulled ahead of the other in Year 1
Combined, WBRBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WBRBF + PFE for your $10,000?
Wienerberger AG produces and sells bricks, roof tiles, concrete pavers, and pipe systems in Europe. It operates through Wienerberger Building Solutions, Wienerberger Piping Solutions, and North America segments. The company offers clay blocks for exterior walls, load and non-load-bearing interior walls, and partition walls, as well as for infill and separating walls under the Porotherm and POROTON brand names; facing bricks for façades under the Terca brand, and ceramic façade tiles under the Argeton brand for hospitals, schools, factories, and offices; clay roof tiles under the Koramic, Sandtoft, and Tondach brands; vitrified clay pipes and fittings, shafts, and accessories for sewage systems; and concrete and clay pavements for various applications that include pedestrian zones, public spaces in train stations or airports, and private terraces or gardens under the Semmelrock brand name, as well as paving bricks and terrace tiles under the Penter brand. It also provides plastic pipes, pipe systems, and pipe fittings for sewage disposal and rainwater drainage; sanitation and heating technology; and supplying energy, gas, and drinking water under the Pipelife brand. Wienerberger AG was founded in 1819 and is headquartered in Vienna, Austria.
Full WBRBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.